艾美捷抗人干擾素α單抗(MT1)能夠在 ELISA 和 ELISpot 等免疫測定中靈敏且特異地檢測人 IFN-α（亞型 2）。

推薦 MT1 作為 ELISA 和 ELISpot 中的捕獲抗體與生物素化檢測抗體 MT2 結(jié)合使用。

艾美捷抗人干擾素α單抗(MT1)化學(xué)性質(zhì)：

英文名稱：Anti-human IFN-alpha mAb (MT1), unconjugated

編號：3423-3-1000

規(guī)格：1mg

應(yīng)用類型：ELISpot, ELISA

免疫原：天然和重組人IFN-alpha亞型2a, 2b, 2c

來源宿主：小鼠

反應(yīng)性：人

保存建議：建議2-8°C保存，有效期為18個月。

艾美捷抗人干擾素α單抗(MT1)相關(guān)研究：

3423-3-250  Anti-human IFN-α mAb (MT1), unconjugated  250 µg  Human

3423-3-1000  Anti-human IFN-α mAb (MT1), unconjugated  1 mg  Human

3423-6-250  Anti-human IFN-α mAb (MT2), biotin  250 µg  Human

3423-6-1000  Anti-human IFN-α mAb (MT2), biotin  1 mg  Human

艾美捷抗人干擾素α單抗(MT1)相關(guān)文獻參考：

Bijak, M., et al. (2017). Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets ａnd Leukocytes. Nutrients.

Chan, L. J., et al. (2017). An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure ａnd Antiviral Activity of Interferon after Subcutaneous Administration. Biomacromolecules.

Hochmann, S., et al. (2018). Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer. Sci Rep.

Ingelsson, B., et al. (2018). Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG ａnd non-CpG oligodeoxynucleotides of class C. Proceedings of the National Academy of Sciences of the United States of America.

Yadav, P., et al. (2018). Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size-dependent ａnd primarily occurs within the liver ａnd mesentery. J Control Release.

來源：https://www.amyjet.com/products/3423-3-1000.shtml